Table 2 Cytokines and Receptors.

From: Specific inhibition of ICAM-1 effectively reduces bladder inflammation in a rat model of severe non-bacterial cystitis

Cytokine or Receptor

Control (7)

Model (9)

Model + Clb (10)

Model + Apt (10)

Model + AIA (10)

M ± SE

M ± SE

P vs Control

M ± SE

P vs Control

P vs Model

M ± SE

P vs Control

P vs Model

M ± SE

P vs Control

P vs Model

P vs Clb

P vs Apt

P2X3 (ng/ml)

42.11 ± 7.21

280.87 ± 0.17

<0.001

182.74 ± 21.32

0.001

0.011

238.57 ± 21.27

<0.001

0.459

140.46 ± 18.09

0.003

<0.001

0.745

0.024

P2Y2 (ng/ml)

93.47 ± 0.14

354.70 ± 20.75

<0.001

169.40 ± 12.45

0.002

<0.001

188.12 ± 0.15

<0.001

<0.001

122.33 ± 14.12

0.429

<0.001

0.183

0.010

PGE2 (ng/ml)

15.06 ± 0.02

160.35 ± 19.78

<0.001

51.29 ± 4.61

<0.001

0.004

30.19 ± 0.01

<0.001

0.001

18.80 ± 0.79

0.009

0.001

<0.001

<0.001

EP1R (ng/ml)

7.30 ± 0.17

79.75 ± 9.44

<0.001

26.17 ± 2.66

0.001

0.003

16.28 ± 0.01

<0.001

0.003

11.59 ± 0.65

0.001

0.001

0.003

<0.001

EP2R (ng/ml)

5.04 ± 0.01

80.21 ± 9.99

<0.001

30.58 ± 4.87

0.005

0.007

20.04 ± 0.01

<0.001

0.006

8.54 ± 1.50

0.296

0.001

0.011

<0.001

TNF-α (ng/ml)

10.83 ± 0.16

123.14 ± 15.99

<0.001

51.30 ± 14.82

<0.001

0.040

28.53 ± 2.78

<0.001

0.003

21.82 ± 0.84

<0.001

0.002

0.046

0.292

NK1R (ng/ml)

15.42 ± 0.10

77.36 ± 7.97

<0.001

32.30 ± 1.85

0.001

0.003

32.97 ± 0.19

<0.001

0.004

21.99 ± 1.43

0.011

0.001

0.004

<0.001

ICAM-1 (pg/ml)

40.28 ± 5.76

334.18 ± 41.78

<0.001

201.37 ± 20.16

<0.001

0.118

150.38 ± 16.30

<0.001

0.017

125.06 ± 15.98

0.004

0.007

0.076

0.942

  1. The data are presented as the means ± standard error (M ± SE). Two-way ANOVA, followed by Dunnett’s T multiple comparison test, was conducted to analyze parametric data. A value of P < 0.05 was considered a significant difference. The three intervention groups (Celecoxib, Aprepitant and AIA) represent NBC rats that received each drug. Clb: Celecoxib; Apt: Aprepitant; AIA: Anti-ICAM-1 antibody.